Heylth Group Information

Heylth Inc., USA, is building an AI-enabled healthcare and life-sciences ecosystem spanning the journey from scientific innovation to clinical adoption, patient care and longer, healthier lives. We believe healthcare requires a connected infrastructure,one that brings together scientific communication, clinical intelligence, early detection, patient engagement, longitudinal monitoring, preventive interventions and therapeutic innovation. We see communication as an essential part of this infrastructure. Scientific advances create meaningful value only when they are understood by healthcare professionals, integrated into clinical practice and translated into better patient experiences and outcomes. Heylth works across this continuum through: • Life Sciences & Pharma Solutions: AI-enabled brand strategy, HCP engagement, field-force effectiveness, medical communications, capability development and international growth for pharmaceutical, biotechnology and medical-device companies • Doctor & Hospital Solutions: AI-ready medical websites, patient screening and engagement applications, digital patient acquisition and international patient pathways for doctors, clinics and hospitals • Heylth Virtual Hospitals: technology-enabled second opinions, specialist access and diagnostic-review pathways • Amriscan: longevity radiology and preventive diagnostic intelligence • Ageless100: AI-enabled healthspan assessment, monitoring and preventive-health pathways • AntiZones: longevity-focused biotechnology and therapeutic innovation These activities address connected parts of the same healthcare journey: developing innovation, communicating evidence, supporting clinical adoption, connecting patients with appropriate care, detecting risk earlier and enabling more personalized preventive interventions.